Condensed Statement of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021
Cash flow from operating activities:
Net loss	$ (500,652)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned in Trust Account	(2,822)
Transaction costs allocable to warrant liability	269,805
Changes in operating assets and liabilities:
Prepaid expenses	(450,406)
Accounts payable and accrued expenses	13,915
Net cash used in operating activities	(670,160)
Cash flows from investing activities:
Investment of cash in Trust Account	(236,527,840)
Net cash used in investing activities	(236,527,840)
Cash flows from financing activities:
Proceeds from sale of Units, net of underwriting discounts paid	238,277,845
Proceeds from sale of Class B common stock	25,000
Proceeds from promissory note payable - related party	105,000
Repayment of promissory note payable - related party	(105,000)
Payments of deferred offering costs	(418,700)
Net cash provided by financing activities	237,884,145
Net change in cash	686,145
Cash at the beginning of the period
Cash at the end of the period	686,145
Supplemental schedule of noncash investing and financing activities:
Initial classification of Class A shares subject to redemption	236,527,842
Change in value of Class A shares subject to redemption	2,822
Deferred underwriting fee payable	8,278,474
Initial measurement of warrants issued in connection with the Public offering accounted for as liabilities	$ 4,860,214